Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Genomics & Liquid Biopsy

Bert Vogelstein

伯特·沃格尔斯坦

MD

🏢Johns Hopkins University School of Medicine(约翰·霍普金斯大学医学院)🌐USA

Clayton Professor of Oncology; Investigator, Howard Hughes Medical Institute克莱顿肿瘤学教授;霍华德·休斯医学研究所研究员

138
h-index
3
Key Papers
8
Awards
4
Key Contributions

👥Biography 个人简介

Bert Vogelstein is the Clayton Professor of Oncology at Johns Hopkins and an HHMI Investigator. He is the most-cited biomedical scientist in history, with over 300,000 total citations. His foundational discoveries have shaped modern oncology more than perhaps any other living scientist. Vogelstein's laboratory discovered or co-discovered: the multistep genetic model of colorectal cancer (showing cancer requires sequential accumulation of driver mutations), the role of APC in colon cancer initiation, that p53 is the most commonly mutated gene in human cancer, and the concept of driver vs. passenger mutations. More recently, his laboratory has pioneered cancer early detection using liquid biopsy approaches including the CancerSEEK multi-analyte blood test and ctDNA-based minimal residual disease testing. He has cofounded multiple companies including Personal Genome Diagnostics.

Bert Vogelstein 是约翰·霍普金斯大学的克莱顿肿瘤学教授,也是HHMI研究员。他是历史上被引用次数最多的生物医学科学家,总引用次数超过300,000次。他的奠基性发现比任何其他在世科学家更深刻地塑造了现代肿瘤学。 Vogelstein的实验室发现或共同发现了:结直肠癌的多步骤遗传模型(表明癌症需要驱动突变的序列积累)、APC在结肠癌启动中的作用、p53是人类癌症中最常见的突变基因,以及驱动突变与乘客突变的概念。

Share:

🧪Research Fields 研究领域

Cancer Genetics & Tumor Suppressor Genes癌症遗传学与肿瘤抑制基因
p53 Discoveryp53发现
Colorectal Cancer Multistep Model结直肠癌多步骤模型
Cancer Evolution & Clonal Dynamics癌症进化与克隆动态
Cancer Early Detection Research癌症早期检测研究

🎓Key Contributions 主要贡献

Multistep Model of Colorectal Cancer

Established the foundational model showing colorectal cancer develops through sequential accumulation of somatic mutations in specific driver genes (APC→KRAS→SMAD4→TP53), providing the paradigm for understanding cancer as an evolutionary genetic process.

p53 as Universal Cancer Gatekeeper

Demonstrated that TP53 is mutated in >50% of all human cancers, establishing it as the most important tumor suppressor gene. p53 research has guided decades of drug discovery and become the most studied gene in cancer biology.

Driver vs. Passenger Mutation Concept

Distinguished "driver" mutations that causally contribute to cancer from "passenger" mutations that are hitchhikers — a fundamental classification enabling identification of therapeutic targets amid complex cancer genomes.

CancerSEEK & Liquid Biopsy

Led development of CancerSEEK multi-analyte blood test for early detection of 8 cancer types. This work, building on 40 years of cancer genetics, represents the culmination of his mission to make cancer detectable before it becomes incurable.

Representative Works 代表性著作

[1]

Genetic alterations during colorectal-tumor development

New England Journal of Medicine (1988)

Landmark paper establishing the adenoma-to-carcinoma multistep genetic model for colorectal cancer, the most influential cancer evolution framework.

[2]

p53 mutations in human cancers

Science (1991)

Comprehensive analysis showing p53 mutations in every major human cancer type, establishing TP53 as the universal cancer gene.

[3]

Cancer as an evolutionary and ecological process

Nature Reviews Cancer (2006)

Influential framework applying evolutionary and ecological principles to explain cancer development, heterogeneity, and progression.

🏆Awards & Recognition 奖项与荣誉

🏆National Medal of Science (2011)
🏆Lasker~Koshland Special Achievement Award in Medical Science (2017)
🏆Breakthrough Prize in Life Sciences (2013)
🏆Gairdner International Award
🏆AACR Margaret Foti Award
🏆Charles S. Mott Prize
🏆Kettering Prize
🏆Paul Ehrlich and Ludwig Darmstaedter Prize

📄Data Sources 数据来源

Last updated: 2026-04-05 | All information from publicly available academic sources

关注 伯特·沃格尔斯坦 的研究动态

Follow Bert Vogelstein's research updates

留下邮箱,当我们发布与 Bert Vogelstein(Johns Hopkins University School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment